Clinical Trials Browser

Phase 1 × Withdrawn × poly ICLC × Clear all

NCT04799431 2023-05-09

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Phase 1 Withdrawn

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms

NCT03068832 2021-05-25

Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors

Phase 1 Withdrawn

Pediatric Brain Tumor